Clinical Trial Update: Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

View source ↗

Summary

A registry study sponsored by Novartis to collect information on patients diagnosed with spinal muscular atrophy; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Muscular Atrophy

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Spinal Muscular Atrophy (SMA) | Status: RECRUITING